Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

OSEFx 2021 – Oxford Saïd Entrepreneurship Forum

External Virtual

Friday, 26 February 2021, 9am to 5pm

OSEFx is a free, virtual conference that introduces you to the most pioneering entrepreneurs and the most cutting-edge ventures. The forum is open to all and provides a platform for impactful networking to build relationships with budding entrepreneurs and investors.

Oxford Talks - CRISPR-Cas9: Genome Editing and the Future of Medicine

External Virtual

Tuesday, 02 March 2021

In 2012, Professor Doudna and Emmanuelle Charpentier were the first to propose that CRISPR-Cas9 (enzymes from bacteria that control microbial immunity) could be used for programmable editing of genomes, which is now considered one of the most significant discoveries in the history of biology.

Industry Insights Seminar Series: Transforming the path for equitable access to rapid diagnostics for epidemics

Internal Virtual

Tuesday, 02 March 2021, 12pm to 1.30pm

This session of the Industry Insights Seminar Series will be presented by Dr Joe Fitchett - Medical Director, Mologic.

OxLEP Webinar - An Investor's Perspective: What do they look for?

David Murray-Hundley, Serial Investor and Entrepreneur

External Virtual

Wednesday, 03 March 2021, 12pm to 1pm

Join OxLEP and serial investor and entrepreneur, David Murray-Hundley, for a 60-minute lunch and learn session. Hear first-hand from a seasoned investor who sits on both sides of the fence, with experience of both raising capital and investing.

IDEA - Ask Me Anything with Diana Torgersen


Thursday, 04 March 2021, 12.30pm to 1.30pm

The first IDEA "Ask Me Anything" with Diana Torgersen, Venture Investor at Novo Holdings. Diana is a venture capital at Novo Holdings, a global life science investor. She has a DPhil in Cell Biology from the University of Oxford, and has worked with biotech companies at all stages of their development.

Ask the Expert - Innovate UK

External Virtual

Friday, 05 March 2021, 10am to 2pm

The UK’s innovation agency, Innovate UK, helps ambitious companies to develop innovative new products and services.

International Women’s Day Virtual Networking Event #ChooseToChallenge

External Virtual

Friday, 05 March 2021, 12pm to 1.30pm

You are invited to celebrate this year’s International Women’s Day with WeAreTheCity and WeAreTechWomen. Join them for a different kind of online networking.

OxLEP Skills for Business: Structuring for High Performance

External Virtual

Tuesday, 09 March 2021, 12pm to 1pm

This workshop, aimed at small business owners with plans for growth, OxLEP will explain how to create the foundations for a high-performance culture, how to identify your employee’s behavioural preferences, and how to set clear objectives and then adapt your leadership style to help then to achieve.

OBN Digital BioTuesday: Supporting the Life Sciences Innovation Ecosystem in Oxfordshire

External Virtual

Tuesday, 09 March 2021, 5pm to 7pm

This session, kindly hosted by Ipsen Bioinnovation based on Milton Park, will gather a group of some of the most interesting life sciences R&D companies, also based on the park, to give them the opportunity to showcase their technology to the wider OBN network.

Women in Biotech - Transatlantic

External Virtual

Wednesday, 10 March 2021, 4pm to 7pm

In celebration of International Women's Day on 8 March, BIA is delighted to bring you the first transatlantic Women in Biotech event, which they are running in partnership with the US-based organisation Women In Bio.

Oxford Brooke's Webinar - Women in Innovation: Closing the gender gap

Professor Simonetta Manfredi and Dr Fanya Ismail

External Virtual

Wednesday, 10 March 2021, 6pm to 7pm

Join Professor Simonetta Manfredi in conversation with Dr Fanya Ismail, winner of “Women in Innovation” award 2019 by Innovate UK.

N-Site Expert Advice Clinic

External Virtual

Thursday, 11 March 2021

Following the success of their last clinic, N-Site will hold another Expert Clinic with specialists in life sciences industry, tax advisory, insurance and risk management, IP strategy, legal advice, deal-making and strategic planning, market access and executive search from the N-Site hub.

OBN Digital BioTuesday: How Disruptive will RNA Technology be for Drug Discovery in Life Sciences

External Virtual

Tuesday, 23 March 2021, 5pm to 7pm

Join this OBN Digital BioTuesday, in collaboration with Bruntwood SciTech, which will address the potential that RNA technologies have to disrupt the product development and drug discovery landscape as we know it.

Pitchfest 2021-2022: Investment Readiness Offering for UK SMEs


Tuesday, 27 April 2021

If you have an innovative offering to pitch to investors and your product or service has an international market - Pitchfest is for you! Pitchfest supports innovative and ambitious UK SMEs to get investment ready and develop their investor pitch in order to raise finance.

Biotechgate Digital Partnering

External Virtual

Monday, 03 May 2021 to Friday, 07 May 2021

Join five days of digital partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings. Biotechgate Digital Partnering is designed to support the business development of Biotech, Medtech and Pharma companies.



Thursday, 17 June 2021

BioForward is a full-day event designed to be a practical, ‘one-stop-shop’ that provides leaders of growing Life Sciences companies with the knowledge, skills, connectivity, and services necessary to achieve sustainable commercial success.

BioTrinity 2021


Monday, 21 June 2021 to Friday, 25 June 2021

BioTrinity is a two-day life sciences conference taking place in central London. The core mission of BioTrinity is to inspire growth and create opportunities for all who attend, with the delegate mix including early-stage and emerging biotech, MedTech and digital health companies, big pharma executives and life sciences investors.